Evidence of Epstein Barr Virus Reactivation in Long COVID Patients

A study published on June 17th 2021 shows that the COVID 30% of the long-haul patients have EBV reactivation. Let's review the study and the evidence presented.

Reference to the study
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233978/

Other studies supporting the evidence of EBV in COVID long-haul:
https://pubmed.ncbi.nlm.nih.gov/28956548/
https://pubmed.ncbi.nlm.nih.gov/2987786/
https://pubmed.ncbi.nlm.nih.gov/231279/https://pubmed.ncbi.nlm.nih.gov/33359064/